B. Roehr

936 total citations
168 papers, 675 citations indexed

About

B. Roehr is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, B. Roehr has authored 168 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Economics and Econometrics, 50 papers in General Health Professions and 33 papers in Public Health, Environmental and Occupational Health. Recurrent topics in B. Roehr's work include Healthcare Policy and Management (23 papers), Pharmaceutical industry and healthcare (20 papers) and Primary Care and Health Outcomes (16 papers). B. Roehr is often cited by papers focused on Healthcare Policy and Management (23 papers), Pharmaceutical industry and healthcare (20 papers) and Primary Care and Health Outcomes (16 papers). B. Roehr collaborates with scholars based in United States. B. Roehr's co-authors include and has published in prestigious journals such as Proceedings of the National Academy of Sciences, BMJ and PubMed.

In The Last Decade

B. Roehr

136 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Roehr United States 12 154 140 130 129 122 168 675
Emmanuel Peprah United States 15 174 1.1× 175 1.3× 156 1.2× 120 0.9× 180 1.5× 55 959
Adhra Al‐Mawali Oman 18 118 0.8× 129 0.9× 122 0.9× 175 1.4× 87 0.7× 41 898
Sougat Ray India 11 87 0.6× 77 0.6× 57 0.4× 111 0.9× 65 0.5× 55 568
Stanley Wang United States 13 245 1.6× 81 0.6× 128 1.0× 106 0.8× 367 3.0× 28 898
Thomas Barbera United Kingdom 8 63 0.4× 145 1.0× 202 1.6× 132 1.0× 83 0.7× 10 918
Thenmozhi Mani India 11 158 1.0× 38 0.3× 110 0.8× 58 0.4× 129 1.1× 70 526
Monica Smith United Kingdom 11 133 0.9× 128 0.9× 233 1.8× 340 2.6× 142 1.2× 18 1.2k
Olivier Drouin Canada 13 173 1.1× 114 0.8× 47 0.4× 77 0.6× 141 1.2× 57 693
Carla Saénz United States 12 126 0.8× 53 0.4× 106 0.8× 144 1.1× 57 0.5× 33 574
Mario Antunes Italy 6 369 2.4× 54 0.4× 69 0.5× 37 0.3× 195 1.6× 17 784

Countries citing papers authored by B. Roehr

Since Specialization
Citations

This map shows the geographic impact of B. Roehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Roehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Roehr more than expected).

Fields of papers citing papers by B. Roehr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Roehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Roehr. The network helps show where B. Roehr may publish in the future.

No nodes

All Works

20 of 20 papers shown
1.
Roehr, B.. (2023). US government seeks compensation from Gilead for PrEP research. BMJ. 381. p1025–p1025.
2.
Roehr, B.. (2022). Covid-19: Pandemic has harmed cancer outcomes and widened inequalities, report finds. BMJ. 376. o375–o375. 3 indexed citations
3.
Roehr, B.. (2021). Assisted dying around the world. BMJ. 374. n2200–n2200. 16 indexed citations
4.
Roehr, B.. (2020). Geroscience’s coming of age. BMJ. 370. m1323–m1323. 2 indexed citations
5.
Roehr, B.. (2020). Bringing drug production home: how the US is rebuilding the drug supply chain after covid-19. BMJ. 370. m3393–m3393. 8 indexed citations
6.
Roehr, B.. (2018). FDA announces crackdown on e-cigarettes in bid to reduce teenage vaping. BMJ. 363. k4908–k4908. 4 indexed citations
7.
Roehr, B.. (2018). US hospitals launch non-profit generic drug producer to counter rising prices. BMJ. 362. k3840–k3840. 2 indexed citations
8.
Roehr, B.. (2017). Attempts to ban seven words at CDC are condemned by public health advocates. BMJ. 359. j5912–j5912. 1 indexed citations
9.
Roehr, B.. (2017). Pharma gifts associated with higher number and cost of prescriptions written. BMJ. 359. j4979–j4979. 1 indexed citations
10.
Roehr, B.. (2017). Health leaders blame addiction for US opioid crisis. BMJ. 359. j4814–j4814. 1 indexed citations
11.
Roehr, B.. (2017). Trump declares opioid public health emergency but no extra money. BMJ. 359. j4998–j4998. 8 indexed citations
12.
Roehr, B.. (2017). Coca-Cola is sued over claims of misleading advertising. BMJ. 356. j208–j208. 1 indexed citations
13.
Roehr, B.. (2015). UNAIDS celebrates success in halting spread of HIV and sets goals for 2030. BMJ. 351. h3832–h3832. 5 indexed citations
14.
Roehr, B.. (2015). FDA committee recommends approval for "female Viagra". BMJ. 350(jun05 11). h3097–h3097. 7 indexed citations
15.
Roehr, B.. (2013). Energy drinks: cause for concern or scaremongering?. BMJ. 347(oct24 2). f6343–f6343. 2 indexed citations
16.
Roehr, B.. (2013). Increase in US healthcare costs should be no more than growth rate of economy, report says. BMJ. 346(jan14 2). f233–f233. 2 indexed citations
17.
Roehr, B.. (2012). The slow and unknown route to a cure for AIDS. BMJ. 345(aug10 1). e5265–e5265. 1 indexed citations
18.
Roehr, B.. (2011). Tenofovir works as pre-exposure prophylaxis against HIV, two studies confirm. BMJ. 343(jul15 3). d4540–d4540. 6 indexed citations
19.
Roehr, B.. (2010). Whooping cough outbreak hits several US states. BMJ. 341(aug24 2). c4627–c4627. 23 indexed citations
20.
Roehr, B.. (2009). Should men who have ever had sex with men be allowed to give blood? Yes. BMJ. 338(feb26 1). b311–b311. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuel Peprah Breakdown of academic impact, for papers by Adhra Al‐Mawali Breakdown of academic impact, for papers by Sougat Ray Breakdown of academic impact, for papers by Stanley Wang Breakdown of academic impact, for papers by Thomas Barbera Breakdown of academic impact, for papers by Thenmozhi Mani Breakdown of academic impact, for papers by Monica Smith Breakdown of academic impact, for papers by Olivier Drouin Breakdown of academic impact, for papers by Carla Saénz Breakdown of academic impact, for papers by Mario Antunes
Rankless by CCL
2026